<?xml version="1.0"?>

<document>
	<title>A comparative study of inhaled atropine sulfate and isoproterenol
   hydrochloride in cystic fibrosis.</title>

	<author>Larsen-G-L.</author>
	<author>Barron-R-J.</author>
	<author>Cotton-E-K.</author>
	<author>Brooks-J-G.</author>

	<source>Am-Rev-Respir-Dis. 1979 Mar. 119(3). P 399-407.</source>

	<abstract>To investigate the contribution of vagal tone to the obstructive
   airway disease in cystic fibrosis, we evaluated the pulmonary
   function response to administration of 0.1 mg of atropine sulfate
   per kg of body weight, 0.05 mg of isoproterenol hydrochloride per kg
   of body weight, or isotonic saline (control solution) administered
   by nebulization on 3 different days to each of 10 patients with
   cystic fibrosis in a single blind study.  The doses of atropine
   sulfate and isoproterenol hydrochloride were based on published
   dose-response characteristics of the drugs.  Each day, thoracic gas
   volume and airway resistance were measured in a volume displacement
   body plethysmograph, and maximal expiratory flow-volume curves were
   performed before and at 15, 30, and 60 min after the inhalation.
   After inhalation of saline, group mean values for all pulmonary
   functions indicated greater airway obstruction at 15, 30, and 60 min
   when compared to pretreatment values.  After inhalation of
   isoproterenol and atropine, significant improvement (P &lt; 0.05) was
   noted in maximal expiratory flows at 60 per cent of total lung
   capacity, specific airway conductance, thoracic gas volume, and
   residual volume.  Inhalation of atropine also significantly improved
   maximal expiratory flow at 25 per cent of vital capacity.
   Isoproterenol increased the mean flows by 8 to 46 per cent above
   baseline, and decreased thoracic gas volume and residual volume by
   11 to 16 per cent with the maximal response at 15 or 30 min.
   Atropine increased mean flows by 15 to 77 per cent and decreased
   thoracic gas volume and residual volume by 16 to 25 per cent with
   the maximal effect at 30 to 60 min.  The mean response to atropine,
   expressed as a percentage of baseline, was always greater than or
   equal to that for isoproterenol.  We conclude that vagal tone, which
   may reflect increased irritant receptor activity, contributes to the
   obstructive pulmonary function in cystic fibrosis.  Inhalation of
   atropine sulfate will decrease the pulmonary function abnormality,
   but side effects prohibit its clinical usefulness.</abstract>

	<majorsubject>ATROPINE: du</majorsubject>
	<majorsubject>CYSTIC-FIBROSIS: pp</majorsubject>
	<majorsubject>ISOPROTERENOL: du</majorsubject>
	<majorsubject>RESPIRATION: de</majorsubject>

	<minorsubject>ADOLESCENCE</minorsubject>
	<minorsubject>AEROSOLS</minorsubject>
	<minorsubject>AIRWAY-RESISTANCE: de</minorsubject>
	<minorsubject>ATROPINE: ad, pd</minorsubject>
	<minorsubject>CHILD</minorsubject>
	<minorsubject>COMPARATIVE-STUDY</minorsubject>
	<minorsubject>DOSE-RESPONSE-RELATIONSHIP-DRUG</minorsubject>
	<minorsubject>FEMALE</minorsubject>
	<minorsubject>HUMAN</minorsubject>
	<minorsubject>ISOPROTERENOL: ad, pd</minorsubject>
	<minorsubject>MALE</minorsubject>
	<minorsubject>MAXIMAL-EXPIRATORY-FLOW-RATE</minorsubject>
	<minorsubject>MAXIMAL-EXPIRATORY-FLOW-VOLUME-CURVES</minorsubject>
	<minorsubject>RESIDUAL-VOLUME</minorsubject>
	<minorsubject>TOTAL-LUNG-CAPACITY</minorsubject>
	<minorsubject>VITAL-CAPACITY</minorsubject>

	<reference>001   WEST JR               PEDIATRICS                      13   155 954</reference>
	<reference>002   COOK CD               PEDIATRICS                      24   181 959</reference>
	<reference>003   BEIER FR              AM REV RESPIR DIS               94   430 966</reference>
	<reference>004   GANDEVIA B            ARCH DIS CHILD                  34   511 959</reference>
	<reference>005   POLGAR G              AM J DIS CHILD                 100   733 960</reference>
	<reference>006   MELLINS RB            PEDIATRICS                      41   560 968</reference>
	<reference>007   MEARNS MB             ARCH DIS CHILD                  43   528 968</reference>
	<reference>008   LIFSCHITZ MI          AM REV RESPIR DIS               99   399 969</reference>
	<reference>009   PHELAN PD             ARCH DIS CHILD                  44   393 969</reference>
	<reference>010   FEATHERBY EA          CAN MED ASSOC J                102   835 970</reference>
	<reference>011   ZAPLETAL A            PEDIATRICS                      48    64 971</reference>
	<reference>012   CHANG N               AM REV RESPIR DIS              106   867 972</reference>
	<reference>013   LANDAU LI             J PEDIATR                       82   863 973</reference>
	<reference>014   SHAPIRO GG            PEDIATRICS                      58   740 976</reference>
	<reference>015   DAY G                 ARCH DIS CHILD                  48   355 973</reference>
	<reference>016   SKORECKI K            ACTA PAEDIATR SCAND             65    39 976</reference>
	<reference>017   EMPEY DW              AM REV RESPIR DIS              113   131 976</reference>
	<reference>018   KLOCK LE              AM REV RESPIR DIS              112   371 975</reference>
	<reference>019   CROPP GJA             AM REV RESPIR DIS              112   599 975</reference>
	<reference>020   TAUSSIG LM            J PEDIATR                       82   380 973</reference>
	<reference>021   BARRON R              AM REV RESPIR DIS SUPPL        115   275 977</reference>
	<reference>022   CAVANAUGH MJ          AM REV RESPIR DIS              114   517 976</reference>
	<reference>023   TINKELMAN D           ANN ALLERGY                     38   298 977</reference>
	<reference>024   MERCER TT             ANN ALLERGY                     23   314 965</reference>
	<reference>025   MEAD J                J APPL PHYSIOL                  15   736 960</reference>
	<reference>026   DUBOIS AB             J CLIN INVEST                   35   322 956</reference>
	<reference>027   DUBOIS AB             J CLIN INVEST                   35   322 956</reference>
	<reference>028   POLGAR G              PULMONARY FUNCTION TESTING IN            971</reference>
	<reference>029   WENG TR               AM REV RESPIR DIS               99   879 969</reference>
	<reference>030   DEMUTH GR             PEDIATRICS                      35   200 965</reference>
	<reference>031   MATTHYS H             RESPIRATION                     27   447 970</reference>
	<reference>032   ZAPLETAL A            J APPL PHYSIOL                  26   308 969</reference>
	<reference>033   STEEL RGD             PRIN PROC OF STATISTICS                  960</reference>
	<reference>034   HAHN GJ               BIOMETRIKA                      58   323 971</reference>
	<reference>035   LANDAU LI             AM REV RESPIR DIS              108   593 973</reference>
	<reference>036   MANSELL A             AM REV RESPIR DIS              109   190 974</reference>
	<reference>037   COOPER DM             AM REV RESPIR DIS              109   519 974</reference>
	<reference>038   INGRAM RH             J CLIN INVEST                   59   696 977</reference>
	<reference>039   ALLAN JD              CLIN ALLERGY                     5   255 975</reference>
	<reference>040   WARNER JO             ARCH DIS CHILD                  51   507 976</reference>
	<reference>041   MELLIS CM             PEDIATRICS                      61   446 978</reference>
	<reference>042   WANNER A              AM REV RESPIR DIS              116    73 977</reference>

	<citation>1   BOHADANA AB           CLIN RESP PHYSIOL               16   769 980</citation>
	<citation>2   KATTAN M              THORAX                          35   531 980</citation>
	<citation>3   BERGMAN KR            CHEST                           78   891 980</citation>
	<citation>4   BOUSHEY HA            AM REV RESPIR DIS              121   389 980</citation>
	<citation>5   LARSEN GL             AM J DIS CHILD                 134  1143 980</citation>
	<citation>6   KRAEMER R             PEDIATR RES                     15  1433 981</citation>
	<citation>7   KRADJAN WA            AM REV RESPIR DIS              123   471 981</citation>
	<citation>8   VANASPEREN P          AM J DIS CHILD                 135   815 981</citation>
	<citation>9   GRIFFIN MP            J APPL PHYSIOL                  53  1576 982</citation>
	<citation>10   PAK CCF               AM REV RESPIR DIS              125   331 982</citation>
	<citation>11   DAVIS PB              J CHRON DIS                     36   269 983</citation>
	<citation>12   FRANCIS PB            MED CLIN NORTH AM               67   657 983</citation>
	<citation>13   DAVIS PB              CHEST                           85   802 984</citation>
	<citation>14   HEIDEPRIEM CC         DRUG INTEL CLIN PHARM           19   732 985</citation>
	<citation>15   SCHONI MH             PEDIATR RES                     19    47 985</citation>
	<citation>16   KONIG P               ANN ALLERGY                     55    95 985</citation>
	<citation>17   HORDVIK NL            AM REV RESPIR DIS              131   889 985</citation>
	<citation>18   DARGA LL              PEDIATR PULMONOL                 2    82 986</citation>
	<citation>19   KNOWLES MR            CLIN CHEST MED                   7   285 986</citation>
	<citation>20   BROWN SE              CHEST                           89     7 986</citation>
	<citation>21   BOUCHER RC            TOXICOL APPL PHARMACOL          87   264 987</citation>

</document>
